The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The first edition of the guidelines for the use of ultrasound contrast agents was published in 2004, dealing with liver applications. The second edition of the guidelines in 2008 reflected changes in the available contrast agents and updated the guidelines for the liver, as well as implementing some nonliver applications. The third edition of the contrast-enhanced ultrasound (CEUS) guidelines was the joint World Federation for Ultrasound in Medicine and Biology-European Federation of Societies for Ultrasound in Medicine and Biology (WFUMB-EFSUMB) venture in conjunction with other regional US societies such as Asian Federation of Societies for Ultrasound in Medicine and Biology, resulting in a simultaneous duplicate on liver CEUS in the official journals of both WFUMB and EFSUMB in 2013. However, no guidelines were described mainly for Sonazoid due to limited clinical experience only in Japan and Korea. The new proposed consensus statements and recommendations provide general advice on the use of Sonazoid and are intended to create standard protocols for the use and administration of Sonazoid in hepatic and pancreatobiliary applications in Asian patients and to improve patient management.

Related collections

Most cited references 195

Record: found
Abstract: found
Article: found

Is Open Access

Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Nader N Massarweh, Hashem El-Serag (2017)

Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) are the most frequently occurring types of primary liver cancer and together are among the most common incident cancers worldwide. There are a number of modifiable and nonmodifiable HCC and ICC risk factors that have been reported. A review of the existing literature the epidemiology and risk factors for HCC and ICC was performed. There are a number of major infectious, lifestyle, metabolic, and heritable risk factors for both HCC and ICC. Some of these risk factors are either potentially preventable (eg, alcohol and tobacco use) or are currently treatable (eg hepatitis infection). In most cases, the molecular pathway or mechanism by which these etiologic factors cause primary liver cancer has not been well delineated. However, in nearly all cases, it is believed that a given risk factor causes liver injury and inflammation which results in chronic liver disease. Given the rising prevalence of several common HCC and ICC risk factors in the western world, the best opportunities for improving the care of these patients are either through the prevention of modifiable risk factors that are associated with the development of chronic liver disease or the identification of at risk patients, ensuring they are appropriately screened for the development of primary liver cancer, and initiating treatment early.

0 comments Cited 223 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.

M Claudon, C Dietrich, B Choi … (2013)

Initially, a set of guidelines for the use of ultrasound contrast agents was published in 2004 dealing only with liver applications. A second edition of the guidelines in 2008 reflected changes in the available contrast agents and updated the guidelines for the liver, as well as implementing some non-liver applications. Time has moved on, and the need for international guidelines on the use of CEUS in the liver has become apparent. The present document describes the third iteration of recommendations for the hepatic use of contrast enhanced ultrasound (CEUS) using contrast specific imaging techniques. This joint WFUMB-EFSUMB initiative has implicated experts from major leading ultrasound societies worldwide. These liver CEUS guidelines are simultaneously published in the official journals of both organizing federations (i.e., Ultrasound in Medicine and Biology for WFUMB and Ultraschall in der Medizin/European Journal of Ultrasound for EFSUMB). These guidelines and recommendations provide general advice on the use of all currently clinically available ultrasound contrast agents (UCA). They are intended to create standard protocols for the use and administration of UCA in liver applications on an international basis and improve the management of patients worldwide. © Georg Thieme Verlag KG Stuttgart · New York.

0 comments Cited 107 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: not found
Article: not found

Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008.

L Thorelius, L Bolondi, F Piscaglia … (2008)

0 comments Cited 104 times – based on 0 reviews      Review now

Bookmark

All references

Author and article information

Journal

Journal ID (nlm-ta): Ultrasonography

Journal ID (iso-abbrev): Ultrasonography

Journal ID (publisher-id): USG

Title: Ultrasonography

Publisher: Korean Society of Ultrasound in Medicine

ISSN (Print): 2288-5919

ISSN (Electronic): 2288-5943

Publication date (Print): July 2020

Publication date (Electronic): 27 April 2020

Volume: 39

Issue: 3

Pages: 191-220

Affiliations

[1 ]Department of Radiology, Seoul National University Hospital, Seoul, Korea

[2 ]Department of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Higashi-Osaka, Japan

[3 ]Department of Radiology, Chung Ang University Hospital, Seoul, Korea

[4 ]Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

[5 ]Department of Medical Imaging and Radiological Technology, Yuanpei University of Medical Technology, Hsinchu, Taiwan

[6 ]Department of Radiology, National Yang Ming University, Taipei, Taiwan

[7 ]Department of Radiology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea

[8 ]Laboratory of Biomedical Engineering, Graduate School of Information Science and Technology, Hokkaido University, Sapporo, Japan

[9 ]Department of Ultrasound, Hepatobiliary and Pancreatic Disease, Hyogo College of Medicine, Nishinomiya, Japan

[10 ]Department of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea

[11 ]Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan

[12 ]Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan

[13 ]Department of Gastroenterology, Juntendo University, Tokyo, Japan

[14 ]Department of Gastroenterology and Hepatology, Toho University Medical Center, Tokyo, Japan

[15 ]Department of Gastroenterology and Hepatology, Takamatsu Red Cross Hospital, Takamatsu, Japan

[16 ]Department of Gastroenterology and Hepatology, Wakayama Medical University Hospital, Wakayama, Japan

[17 ]Hepato-Biliary-Pancreatic Surgery Division and Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

[18 ]Department of Gastroenterology and Hepatology, National Taiwan University, Taipei, Taiwan

[19 ]Department of Gastroenterology and Hepatology, Chang Gung University, Taipei, Taiwan

[20 ]Ultrasound Section, Division of Surgery, Department of Gastroenterology, Herlev Hospital, Copenhagen Academy for Medical Education and Simulation, University of Copenhagen, Copenhagen, Denmark

[21 ]National Centre for Ultrasound in Gastroenterology, Haukeland University Hospital, Bergen, Norway

[22 ]Department of Clinical Medicine, University of Bergen, Bergen, Norway

Author notes

Correspondence to: Byung Ihn Choi, MD, Department of Radiology, Chung Ang University Hospital, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Korea Tel. +82-2-6299-3204 Fax. +82-2-6299-2064 E-mail: bichoi@ 123456caumc.or.kr

Masatoshi Kudo, MD, Department of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Higashi-Osaka, Japan Tel. +81-72-366-0221 (ext. 3149) Fax. +81-72-367-2880 E-mail: m-kudo@ 123456med.kindai.ac.jp

[*]

These authors contributed equally to this work.

Author information

Jae Young Lee http://orcid.org/0000-0001-6946-6042

Yasunori Minami http://orcid.org/0000-0001-7146-5954

Byung Ihn Choi http://orcid.org/0000-0002-5613-1881

Won Jae Lee http://orcid.org/0000-0001-5833-989X

Yi-Hong Chou http://orcid.org/0000-0002-7418-4514

Woo Kyoung Jeong http://orcid.org/0000-0002-0676-2116

Mi-Suk Park http://orcid.org/0000-0001-5817-2444

Nobuki Kudo http://orcid.org/0000-0003-3463-3714

Min Woo Lee http://orcid.org/0000-0001-9048-9011

Ken Kamata http://orcid.org/0000-0003-1568-0769

Hiroko Iijima http://orcid.org/0000-0002-5841-8827

So Yeon Kim http://orcid.org/0000-0001-6853-8577

Kazushi Numata http://orcid.org/0000-0003-4671-4431

Katsutoshi Sugimoto http://orcid.org/0000-0001-6271-7806

Hitoshi Maruyama http://orcid.org/0000-0003-3371-3157

Yasukiyo Sumino http://orcid.org/0000-0002-1044-8808

Chikara Ogawa http://orcid.org/0000-0002-4534-6692

Masayuki Kitano http://orcid.org/0000-0001-6885-9223

Ijin Joo http://orcid.org/0000-0002-1341-4072

Junichi Arita http://orcid.org/0000-0003-1929-8479

Ja-Der Liang http://orcid.org/0000-0002-4532-0118

Hsi-Ming Lin http://orcid.org/0000-0001-7527-6181

Christian Nolsoe http://orcid.org/0000-0003-0168-6131

Odd Helge Gilja http://orcid.org/0000-0002-0436-0383

Masatoshi Kudo http://orcid.org/0000-0002-4102-3474

Article

Publisher ID: usg-20057

DOI: 10.14366/usg.20057

PMC ID: 7315291

PubMed ID: 32447876

SO-VID: d0c2a12d-1b24-4f1b-b3a7-74ab93054005

License:

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

History

Date received : 20 April 2020

Date revision received : 20 April 2020

Date accepted : 27 April 2020

Comments

Comment on this article

scite_

Cited by 29

See all cited by

Most referenced authors 1,961

See all reference authors

The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid

Read this article at

Abstract

Related collections

Electron Channelling Contrast Imaging (ECCI)

Most cited references 195

Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.

Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008.

Author and article information

Journal

Affiliations

Author notes

Author information

Article

History

Categories

Comments

Comment on this article

Similar content 333

Cited by 29

Most referenced authors 1,961